- In September 2022, Royal DSM completed the acquisition of Prodap, a Brazil-based animal nutrition and technology company. This development strengthens DSM’s position in precision livestock farming by integrating advanced digital solutions. The acquisition is set to enhance the efficiency and sustainability of animal agriculture through data-driven nutrition management. It supports DSM’s broader strategy to lead in sustainable farming practices. This move is expected to positively impact the market by improving productivity and reducing the environmental footprint of livestock operations
- In August 2022, Medtronic plc completed the acquisition of Affera Inc., a U.S.-based medical technology company specializing in cardiac arrhythmia treatment. This strategic move adds Affera's innovative cardiac mapping and navigation platform to Medtronic's portfolio, enhancing its capabilities in diagnosing and treating heart rhythm disorders. The integration of Affera's technologies is expected to strengthen Medtronic's position in the cardiac ablation market, offering comprehensive solutions for patients with arrhythmias
- In April 2023, Royal DSM completed the sale of its Engineering Materials business to Advent International and LANXESS for an enterprise value of €3.85 billion. This divestment marks DSM's strategic shift to focus on Health and Nutrition sectors. The transaction is expected to generate a book profit of approximately €2.7 billion, with DSM receiving around €3.5 billion in net cash. This move allows DSM to streamline its operations and invest more heavily in its core competencies, potentially enhancing its market position in the health and nutrition industries
- In April 2022, Medtronic and GE Healthcare announced a strategic collaboration aimed at addressing the growing demand for outpatient care. This partnership focuses on providing comprehensive solutions for Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs), integrating Medtronic's medical devices with GE Healthcare's imaging technologies and planning services. The collaboration seeks to enhance efficiency, workflow, and clinical outcomes in outpatient settings, responding to the accelerated shift from traditional hospital procedures to outpatient environments. This move is expected to support healthcare providers in delivering high-quality care while managing costs and complexities associated with expanding or establishing new outpatient facilities
- In December 2021, Royal DSM completed the acquisition of Vestkorn Milling, a leading Norwegian producer of pea- and bean-derived ingredients, for an enterprise value of €65 million. This strategic acquisition enhances DSM's portfolio in the plant-based protein sector, complementing its existing offerings such as vitamins, algal lipids, and minerals. By integrating Vestkorn's expertise in proteins, starches, and dietary fibers, DSM aims to strengthen its position in the alternative protein market. This move aligns with DSM's broader strategy to support sustainable food systems and meet the growing consumer demand for plant-based nutrition
